1: Chi M, Ma K, Wang J, Ding Z, Li Y, Zhu S, Liang X, Zhang Q, Song L, Liu C. The Immunomodulatory Effect of the Gut Microbiota in Kidney Disease. J Immunol Res. 2021 May 15;2021:5516035. doi: 10.1155/2021/5516035. PMID: 34095319; PMCID: PMC8140847.
2: Falconi CA, Junho CVDC, Fogaça-Ruiz F, Vernier ICS, da Cunha RS, Stinghen AEM, Carneiro-Ramos MS. Uremic Toxins: An Alarming Danger Concerning the Cardiovascular System. Front Physiol. 2021 May 14;12:686249. doi: 10.3389/fphys.2021.686249. PMID: 34054588; PMCID: PMC8160254.
3: Rodrigues FG, Ormanji MS, Heilberg IP, Bakker SJL, de Borst MH. Interplay between gut microbiota, bone health and vascular calcification in chronic kidney disease. Eur J Clin Invest. 2021 May 4:e13588. doi: 10.1111/eci.13588. Epub ahead of print. PMID: 33948936.
4: Filipska I, Winiarska A, Knysak M, Stompór T. Contribution of Gut Microbiota- Derived Uremic Toxins to the Cardiovascular System Mineralization. Toxins (Basel). 2021 Apr 10;13(4):274. doi: 10.3390/toxins13040274. PMID: 33920096; PMCID: PMC8070663.
5: Croci S, D'Apolito LI, Gasperi V, Catani MV, Savini I. Dietary Strategies for Management of Metabolic Syndrome: Role of Gut Microbiota Metabolites. Nutrients. 2021 Apr 21;13(5):1389. doi: 10.3390/nu13051389. PMID: 33919016; PMCID: PMC8142993.
6: Rysz J, Franczyk B, Ławiński J, Olszewski R, Ciałkowska-Rysz A, Gluba-Brzózka A. The Impact of CKD on Uremic Toxins and Gut Microbiota. Toxins (Basel). 2021 Mar 31;13(4):252. doi: 10.3390/toxins13040252. PMID: 33807343; PMCID: PMC8067083.
7: Herič T, Vivoda T, Bogataj Š, Pajek J. Medium Cut-Off Dialysis Membrane and Dietary Fiber Effects on Inflammation and Protein-Bound Uremic Toxins: A Systematic Review and Protocol for an Interventional Study. Toxins (Basel). 2021 Mar 29;13(4):244. doi: 10.3390/toxins13040244. PMID: 33805509; PMCID: PMC8066258.
8: Fryc J, Naumnik B. Thrombolome and Its Emerging Role in Chronic Kidney Diseases. Toxins (Basel). 2021 Mar 18;13(3):223. doi: 10.3390/toxins13030223. PMID: 33803899; PMCID: PMC8003125.
9: Saar-Kovrov V, Zidek W, Orth-Alampour S, Fliser D, Jankowski V, Biessen EAL, Jankowski J. Reduction of protein-bound uraemic toxins in plasma of chronic renal failure patients: A systematic review. J Intern Med. 2021 Apr 1. doi: 10.1111/joim.13248. Epub ahead of print. PMID: 33792983.
10: Lim YJ, Sidor NA, Tonial NC, Che A, Urquhart BL. Uremic Toxins in the Progression of Chronic Kidney Disease and Cardiovascular Disease: Mechanisms and Therapeutic Targets. Toxins (Basel). 2021 Feb 13;13(2):142. doi: 10.3390/toxins13020142. PMID: 33668632; PMCID: PMC7917723.
11: Kwiatkowska I, Hermanowicz JM, Mysliwiec M, Pawlak D. Oxidative Storm Induced by Tryptophan Metabolites: Missing Link between Atherosclerosis and Chronic Kidney Disease. Oxid Med Cell Longev. 2020 Dec 29;2020:6656033. doi: 10.1155/2020/6656033. PMID: 33456671; PMCID: PMC7787774.
12: Wu CL, Tarng DC. Targeting Uremic Toxins to Prevent Peripheral Vascular Complications in Chronic Kidney Disease. Toxins (Basel). 2020 Dec 20;12(12):808. doi: 10.3390/toxins12120808. PMID: 33419312; PMCID: PMC7765928.
13: Eshghjoo S, Jayaraman A, Sun Y, Alaniz RC. Microbiota-Mediated Immune Regulation in Atherosclerosis. Molecules. 2021 Jan 1;26(1):179. doi: 10.3390/molecules26010179. PMID: 33401401; PMCID: PMC7795654.
14: Chao CT, Lin SH. Uremic Vascular Calcification: The Pathogenic Roles and Gastrointestinal Decontamination of Uremic Toxins. Toxins (Basel). 2020 Dec 21;12(12):812. doi: 10.3390/toxins12120812. PMID: 33371477; PMCID: PMC7767516.
15: Yaker L, Kamel S, Ausseil J, Boullier A. Effects of Chronic Kidney Disease and Uremic Toxins on Extracellular Vesicle Biology. Toxins (Basel). 2020 Dec 21;12(12):811. doi: 10.3390/toxins12120811. PMID: 33371311; PMCID: PMC7767379.
16: Nagata D, Yoshizawa H. Pharmacological Actions of Indoxyl Sulfate and AST-120 That Should Be Recognized for the Strategic Treatment of Patients with Chronic Kidney Disease. Int J Nephrol Renovasc Dis. 2020 Dec 4;13:359-365. doi: 10.2147/IJNRD.S287237. PMID: 33311993; PMCID: PMC7726832.
17: Ikee R, Sasaki N, Yasuda T, Fukazawa S. Chronic Kidney Disease, Gut Dysbiosis, and Constipation: A Burdensome Triplet. Microorganisms. 2020 Nov 25;8(12):1862. doi: 10.3390/microorganisms8121862. PMID: 33255763; PMCID: PMC7760012.
18: Colombo I, Aiello-Battan F, Elena R, Ruiz A, Petraglia L, Musso CG. Kidney- gut crosstalk in renal disease. Ir J Med Sci. 2020 Nov 20. doi: 10.1007/s11845-020-02437-7. Epub ahead of print. PMID: 33216316.
19: Cheng TH, Ma MC, Liao MT, Zheng CM, Lu KC, Liao CH, Hou YC, Liu WC, Lu CL. Indoxyl Sulfate, a Tubular Toxin, Contributes to the Development of Chronic Kidney Disease. Toxins (Basel). 2020 Oct 29;12(11):684. doi: 10.3390/toxins12110684. PMID: 33138205; PMCID: PMC7693919.
20: Beloborodova NV, Chernevskaya EA, Getsina ML. Indolic Structure Metabolites as Potential Biomarkers of Non-infectious Diseases. Curr Pharm Des. 2021;27(2):238-249. doi: 10.2174/1381612826666201022121653. PMID: 33092503.